{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T23:22:38Z","timestamp":1787008958730,"version":"build-2736575974"},"reference-count":23,"publisher":"Oxford University Press (OUP)","issue":"4","license":[{"start":{"date-parts":[[2020,12,11]],"date-time":"2020-12-11T00:00:00Z","timestamp":1607644800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2021,4,19]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>OBJECTIVES<\/jats:title>\n                    <jats:p>Primary graft dysfunction after heart transplant is associated with high morbidity and mortality. Extracorporeal membrane oxygenation (ECMO) can be used to wean patients from cardiopulmonary bypass. This study retrospectively reviews a single-centre experience of post-transplant ECMO in regard to outcomes and associated costs.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>METHODS<\/jats:title>\n                    <jats:p>Between May 2006 and May 2019, a total of 267 adult heart transplants were performed. We compared donor and recipient variables, ECMO duration and the incidence of renal failure, bleeding, infection and cost analysis between ECMO and non-ECMO groups.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>RESULTS<\/jats:title>\n                    <jats:p>ECMO support was required postoperatively to manage primary graft dysfunction in 72 (27%) patients. The mean duration of ECMO support was 6\u2009\u00b1\u20093.2\u2009days. Mean ischaemic times were similar between the groups. There was a significantly higher proportion of ventricular assist device explant to transplant in the ECMO group versus non-ECMO (38.2% vs 14.1%; P\u2009&amp;lt;\u20090.0001). ECMO patients had a longer duration of stay in the intensive care unit (P\u2009&amp;lt;\u20090.0001) and total hospital stay (P\u2009&amp;lt;\u20090.0001). Greater mortality was observed in the ECMO group (P\u2009&amp;lt;\u20090.0001). The median cost of providing ECMO was \u00a318\u00a0000 [interquartile range (IQR): \u00a312\u00a0750\u2013\u00a324\u00a0000] per patient with an additional median \u00a335\u00a0225 (IQR: \u00a321\u00a0487.25\u2013\u00a351\u00a0780.75) for ITU stay whilst on ECMO. The total median cost per patient inclusive of hospital stay, ECMO and dialysis costs was \u00a365\u00a0737.50 (IQR: \u00a352\u00a0566.50\u2013\u00a395\u00a0221.75) in the non-ECMO group compared to \u00a3145\u00a0415.71 (IQR: \u00a3102\u00a0523.21\u2013\u00a3200\u00a0618.96) per patient in the ECMO group (P\u2009&amp;lt;\u20090.0001).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>CONCLUSIONS<\/jats:title>\n                    <jats:p>Patients with primary graft dysfunction following heart transplantation who require ECMO are frequently bridged to a recovery; however, the medium and longer-term survival for these patients is poorer than for patients who do not require ECMO.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1093\/icvts\/ivaa307","type":"journal-article","created":{"date-parts":[[2020,11,16]],"date-time":"2020-11-16T07:12:46Z","timestamp":1605510766000},"page":"625-631","source":"Crossref","is-referenced-by-count":4,"title":["Financial implications of using extracorporeal membrane oxygenation following heart transplantation"],"prefix":"10.1093","volume":"32","author":[{"given":"Bhuvaneswari","family":"Krishnamoorthy","sequence":"first","affiliation":[{"name":"Department of Cardiothoracic Surgery, Manchester Foundation Trust, Manchester, UK"},{"name":"Department of Allied Health Professions, Faculty of Health and Social Service, Edgehill University, Manchester, UK"},{"name":"Department of Cardiovascular Sciences, Faculty of Health, Biology and Medicine, University of Manchester, Manchester, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6794-6034","authenticated-orcid":false,"given":"Vipin","family":"Mehta","sequence":"additional","affiliation":[{"name":"Department of Cardiothoracic Surgery, Manchester Foundation Trust, Manchester, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William","family":"Critchley","sequence":"additional","affiliation":[{"name":"Department of Endothelial Cell Biology Unit, School of Molecular and Cellular Biology, University of Leeds, Leeds, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul","family":"Callan","sequence":"additional","affiliation":[{"name":"Department of Cardiothoracic Surgery, Manchester Foundation Trust, Manchester, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steve","family":"Shaw","sequence":"additional","affiliation":[{"name":"Department of Cardiothoracic Surgery, Manchester Foundation Trust, Manchester, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rajamiyer","family":"Venkateswaran","sequence":"additional","affiliation":[{"name":"Department of Cardiothoracic Surgery, Manchester Foundation Trust, Manchester, UK"},{"name":"Department of Cardiovascular Sciences, Faculty of Health, Biology and Medicine, University of Manchester, Manchester, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2020,12,11]]},"reference":[{"key":"2021042109245700800_ivaa307-B1","doi-asserted-by":"crossref","first-page":"75","DOI":"10.21037\/acs.2018.01.08","article-title":"Heart transplantation from donation after circulatory determined death","volume":"7","author":"Page","year":"2018","journal-title":"Ann Cardiothorac Surg"},{"key":"2021042109245700800_ivaa307-B2"},{"key":"2021042109245700800_ivaa307-B3","doi-asserted-by":"crossref","first-page":"1461","DOI":"10.1111\/ajt.14588","article-title":"Primary graft dysfunction after heart transplantation: incidence, trends, and associated risk factors","volume":"18","author":"Nicoara","year":"2018","journal-title":"Am J Transplant"},{"key":"2021042109245700800_ivaa307-B4","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1097\/MOT.0000000000000523","article-title":"Primary graft dysfunction in heart transplantation","volume":"23","author":"DePasquale","year":"2018","journal-title":"Curr Opin Organ Transplant"},{"key":"2021042109245700800_ivaa307-B5","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1097\/TP.0000000000002220","article-title":"ISHLT primary graft dysfunction incidence, risk factors, and outcome: a UK national study","volume":"103","author":"Avtaar Singh","year":"2019","journal-title":"Transplantation"},{"key":"2021042109245700800_ivaa307-B6","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/j.healun.2014.02.027","article-title":"Report from a consensus conference on primary graft dysfunction after cardiac transplantation","volume":"33","author":"Kobashigawa","year":"2014","journal-title":"J Heart Lung Transplant"},{"key":"2021042109245700800_ivaa307-B7","doi-asserted-by":"crossref","first-page":"e359","DOI":"10.1097\/CCM.0000000000002995","article-title":"Predicting survival in patients treated with extracorporeal membrane oxygenation after myocardial infarction","volume":"46","author":"Pabst","year":"2018","journal-title":"Crit Care Med"},{"key":"2021042109245700800_ivaa307-B8","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1177\/0885066617751398","article-title":"The use of ECMO for the treatment of refractory cardiac arrest or postarrest cardiogenic shock following in-hospital cardiac arrest: a 10-year experience","volume":"34","author":"Chonde","year":"2019","journal-title":"J Intensive Care Med"},{"key":"2021042109245700800_ivaa307-B9","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1186\/s13019-017-0618-0","article-title":"Extra-corporeal membrane oxygenation for refractory cardiogenic shock after adult cardiac surgery: a systematic review and meta-analysis","volume":"12","author":"Khorsandi","year":"2017","journal-title":"J Cardiothorac Surg"},{"key":"2021042109245700800_ivaa307-B10","doi-asserted-by":"crossref","first-page":"398","DOI":"10.21037\/atm.2017.08.32","article-title":"Extracorporeal life support in preoperative and postoperative heart transplant management","volume":"5","author":"Bermudez","year":"2017","journal-title":"Ann Transl Med"},{"key":"2021042109245700800_ivaa307-B11","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1016\/j.healun.2016.12.006","article-title":"Improved outcomes from extracorporeal membrane oxygenation versus ventricular assist device temporary support of primary graft dysfunction in heart transplant","volume":"36","author":"Takeda","year":"2017","journal-title":"J Heart Lung Transplant"},{"key":"2021042109245700800_ivaa307-B12","doi-asserted-by":"crossref","first-page":"1644","DOI":"10.1016\/j.athoracsur.2004.04.059","article-title":"Extracorporeal membrane oxygenation is superior to right ventricular assist device for acute right ventricular failure after heart transplantation","volume":"78","author":"Taghavi","year":"2004","journal-title":"Ann Thorac Surg"},{"key":"2021042109245700800_ivaa307-B13","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1093\/ejcts\/ezx189","article-title":"Minimally invasive CentriMag ventricular assist device support integrated with extracorporeal membrane oxygenation in cardiogenic shock patients: a comparison with conventional CentriMag biventricular support configuration","volume":"52","author":"Takeda","year":"2017","journal-title":"Eur J Cardiothorac Surg"},{"key":"2021042109245700800_ivaa307-B14","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1097\/MAT.0000000000000117","article-title":"Thoratec CentriMag for temporary treatment of refractory cardiogenic shock or severe cardiopulmonary insufficiency: a systematic literature review and meta-analysis of observational studies","volume":"60","author":"Borisenko","year":"2014","journal-title":"ASAIO J"},{"key":"2021042109245700800_ivaa307-B15","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1093\/ejcts\/ezt125","article-title":"Acute lung injury after mechanical circulatory support implantation in patients on extracorporeal life support: an unrecognized problem","volume":"44","author":"Boulate","year":"2013","journal-title":"Eur J Cardiothorac Surg"},{"key":"2021042109245700800_ivaa307-B16","first-page":"285","article-title":"Experience of ECMO in primary graft dysfunction after orthotopic heart transplantation","volume":"105","author":"Lima","year":"2015","journal-title":"Arq Bras Cardiol"},{"key":"2021042109245700800_ivaa307-B17","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1111\/petr.12382","article-title":"Extracorporeal membrane oxygenation support after pediatric orthotopic heart transplantation","volume":"19","author":"Su","year":"2015","journal-title":"Pediatr Transplant"},{"key":"2021042109245700800_ivaa307-B18","doi-asserted-by":"crossref","first-page":"100","DOI":"10.5090\/kjtcs.2014.47.2.100","article-title":"Percutaneous extracorporeal membrane oxygenation for graft dysfunction after heart transplantation","volume":"47","author":"Lim","year":"2014","journal-title":"Korean J Thorac Cardiovasc Surg"},{"key":"2021042109245700800_ivaa307-B19","doi-asserted-by":"crossref","first-page":"1250","DOI":"10.1016\/j.healun.2011.05.006","article-title":"Heart transplant recipients supported with extracorporeal membrane oxygenation: outcomes from a single-center experience","volume":"30","author":"Kittleson","year":"2011","journal-title":"J Heart Lung Transplant"},{"key":"2021042109245700800_ivaa307-B20","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1016\/j.healun.2011.01.728","article-title":"Usefulness of extracorporeal membrane oxygenation for early cardiac allograft dysfunction","volume":"30","author":"Listijono","year":"2011","journal-title":"J Heart Lung Transplant"},{"key":"2021042109245700800_ivaa307-B21"},{"key":"2021042109245700800_ivaa307-B22","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1016\/j.healun.2017.03.018","article-title":"Ventricular assist device elicits serum natural IgG that correlates with the development of primary graft dysfunction following heart transplantation","volume":"36","author":"See","year":"2017","journal-title":"J Heart Lung Transplant"},{"key":"2021042109245700800_ivaa307-B23","first-page":"343","article-title":"Extra-corporeal membrane oxygenation temporary support for early graft failure after cardiac transplantation","volume":"37","author":"D'Alessandro","year":"2010","journal-title":"Eur J Cardiothorac Surg"}],"container-title":["Interactive CardioVascular and Thoracic Surgery"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/icvts\/article-pdf\/32\/4\/625\/37218017\/ivaa307.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/academic.oup.com\/icvts\/article-pdf\/32\/4\/625\/37218017\/ivaa307.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,4,21]],"date-time":"2021-04-21T19:07:59Z","timestamp":1619032079000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/icvts\/article\/32\/4\/625\/6031441"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,12,11]]},"references-count":23,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2020,12,11]]},"published-print":{"date-parts":[[2021,4,19]]}},"URL":"https:\/\/doi.org\/10.1093\/icvts\/ivaa307","relation":{},"ISSN":["1569-9285"],"issn-type":[{"value":"1569-9285","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2021,4,1]]},"published":{"date-parts":[[2020,12,11]]}}}